# Drug Intervention in Chronic Fatigue Syndrome

> **NCT00848692** · PHASE2,PHASE3 · COMPLETED · sponsor: **Haukeland University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Chronic Fatigue Syndrome

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Saline (NaCl 0,9 %) (placebo)

## Key facts

- **NCT ID:** NCT00848692
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00848692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00848692, "Drug Intervention in Chronic Fatigue Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00848692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*